J-REIT Data

8972 KDX Investment Corporation

ケネディクス不動産投資法人が第6期決算を発表、1口当たり実績分配金は16,711円

(Jun. 11, 2008)

ケネディクス不動産投資法人が第6期(平成20年4月期)決算を発表した。第6期は、オフィスビル14棟取得、レジデンス23棟売却によって、ポートフォリオを従来の総合型からオフィスビル主体へ移行。物件売却益9.5億円が寄与し、前期比19.7%増益、1口当たり分配金は16,711円となった。第7期(平成20年10月期)は、2棟取得する一方、前期の物件売却益がなくなるため、10%減益、1口当たり分配金は15,000円となる見通し。今後さらにオフィスビルの投資比率を上げていく意向。併せて、保有する福岡の都市型商業施設1棟を売却に向けて協議中であることを発表。売却価格が決定次第、6月中に売却する予定。

  第6期実績 第7期予想 前期比
営業収益 8,582百万円 8,174百万円 ▲4.8%
当期利益 3,342百万円 3,002百万円 ▲10.2%
分配金
(/1口)
16,711円 15,000円 ▲10.2%

Recent 5 news of KDX Investment Corporation
Nov. 6, 2014
Kenedix Office Investment Corporation : Issuance of New Investment Units and Secondary Offering of Investment Units, Acquisition of 5 Properties
Oct. 15, 2014
Kenedix Office Investment Corporation : Acquisition of "Urban Square Yokohama"
Sep. 30, 2014
Kenedix Office Investment Corporation to Acquire " Senri Life Science Center Building"
Aug. 25, 2014
Kenedix Office Investment Corporation to Acquire 2 Office Buildings.
Jul. 8, 2014
Kenedix Office Investment Corporation Sells KDX Minami Semba Dai-1 Building / Nissou Dai-17 Building, and announced the refund of Preferred Securities.

ReitInfo.com

Property Acquisition Price Rankings

(Billions of yen)

1 Shinjuku Mitsui Bldg. 170
2 IIDABASHI GRAND BLOOM 139
3 Roppongi Hills Mori Tower 115
4 Shiodome Building 107
5 Tokyo Shiodome Building 83
Unit Price Growth Rankings
1 Nippon Prologis +1.86%
2 Daiwa House REIT +1.82%
3 CRE Logistics +1.77%
* This website provides information and data on J-REITs and is not intended as a solicitation for investment.
* The information appearing on this website has been carefully vetted, but the accuracy of the content is in no way guaranteed and may change without notice (that is, it may be modified or deleted).
* Users shall be responsible for the use of the information published on this website. The Company cannot be held liable whatsoever regarding the use of this information.
* Copyrights related to the information published on this website belong to the Company. The unauthorized use (diversion or reproduction, etc.) of this information is strictly prohibited.